Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,562.44
(
0.56%
)
US TECH 100
29,431.20
(
0.87%
)
Dow Jones
50,631.64
(
-0.02%
)
Brent Oil
92.65
(
0.23%
)
Bitcoin
73,503.25
(
-1.85%
)
News Focus
News Focus
Post# of 2382217
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trooperstocks

Send PM Follow Ignore
Followers 1357
Posts 276484
Boards Moderated 51
Alias Born 12/07/2009

Trooperstocks

Member Level

Re: None

Friday, 09/20/2024 8:26:28 AM

Friday, September 20, 2024 8:26:28 AM

Post# of 2382217
$CVKD - Zacks initiating coverage of Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) with a $30.00 valuation. Cadrenal is a biopharmaceutical developing innovative therapies for life-threatening cardiovascular and renal diseases. https://scr.zacks.com/news/news-details/2024/CVKD-New-Blood-Thinner-Ready-for-Phase-3-Initiating-Coverage-of-Cadrenal-Therapeutics-Inc-article/default.aspx

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today